DPP-4 inhibitors can cause severe adverse effects such as hypersensitivity reactions (Stevens–Johnson syndrome, anaphylaxis, bullous pemphigoid), infections, pancreatitis or intestinal obstruction. Here, DPP4 is linked to anaphylaxis.